<DOC>
	<DOCNO>NCT00935415</DOCNO>
	<brief_summary>The aim study verify MNT time onset protection EIB asthmatic child evaluate different time interval dose challenge , single-dose three day day MNT administration .</brief_summary>
	<brief_title>Time-Effect Montelukast Protection</brief_title>
	<detailed_description>Within day baseline exercise challenge , child randomize double blind , placebo-controlled , three day dos , crossover study design . In practice eligible patient randomize computer-generated schedule receive sequence double-blind treatment placebo MNT ( 5 mg ) . Patients sequence 1 receive MNT , cross matching placebo ; vice versa case patient sequence 2 . Placebo active treatment separate 7-10 day wash-out period . Each child assign one seven group order perform exercise challenge different time interval drug administration occur always 8.00 A.M. On day one challenge perform different group 1 , 2 , 3 , 4 , 5 , 6 , 8 hour drug administration , respectively . Then treatment continue single day dose three consecutive day third challenge perform time day .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Asthma , Exercise-Induced</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>child exerciseinduced asthma viral infection montelukast treatment</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>asthma</keyword>
	<keyword>exercise-induced bronchoconstriction</keyword>
	<keyword>montelukast</keyword>
	<keyword>clinical protection</keyword>
	<keyword>child</keyword>
	<keyword>time effect</keyword>
</DOC>